Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A-101 Dose-Response in Seborrheic Keratosis
NCT02160626Phase 2Completed
- Sponsor
- Aclaris Therapeutics, Inc.
- Start
- Jun 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrogen peroxide gel in seborrheic keratosis (SK), sponsored by Aclaris Therapeutics, Inc.. Started Jun 2014; status: completed.
02
Drugs
hydrogen peroxide gel
03
Conditions
seborrheic keratosis (SK)
Beyond the preview
Go deeper on NCT02160626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160626.